Ratings by RBC Capital (Dan Leonard)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2026 | Bio-Techne Corp. | TECH | Downgrade | Sector Perform (Outperform) |
70.61 (72.12) |
2.14% | Details | |
| 6/11/2026 | Guardant Health | GH | New Coverage | Outperform (N/A) |
130.70 (155.87) |
19.26% | Details | |
| 6/11/2026 | Natera | NTRA | New Coverage | Outperform (N/A) |
216.50 (271.39) |
25.35% | Details | |
| 5/28/2026 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2026 | Agilent | A | New Coverage | Outperform (N/A) |
114.96 (131.46) |
14.35% | Details | |
| 5/14/2026 | Bio-Rad Labs | BIO | New Coverage | Outperform (N/A) |
243.51 (304.36) |
24.99% | Details | |
| 5/14/2026 | Avantor Inc. | AVTR | New Coverage | Sector Perform (N/A) |
7.87 (11.07) |
40.66% | Details | |
| 5/14/2026 | Repligen | RGEN | New Coverage | Outperform (N/A) |
107.03 (147.25) |
37.58% | Details | |
| 5/14/2026 | Danaher | DHR | New Coverage | Outperform (N/A) |
165.99 (203.83) |
22.8% | Details | |
| 5/14/2026 | Illumina | ILMN | New Coverage | Outperform (N/A) |
145.00 (186.65) |
28.72% | Details | |
| 5/14/2026 | Thermo Fisher Scientific | TMO | New Coverage | Sector Perform (N/A) |
446.03 (532.48) |
19.38% | Details | |
| 5/14/2026 | Bio-Techne Corp. | TECH | New Coverage | Outperform (N/A) |
44.89 (70.61) |
57.3% | Details |
